Physician profile
Myron Scott Strickland
NPI 1336189505
$4,022.59
in general payments reported to CMS, 2019-2025
41 companies · $258 in 2025
The $258 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,184 · 2020: $317 · 2021: $615 · 2022: $464 · 2023: $651 · 2024: $533 · 2025: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,354 · Education: $88.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,353.88 |
| Education | $88.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $818.28 | 2019-2023 | 1688 |
| Daiichi Sankyo INC. | $399.14 | 2019-2024 | Injectafer |
| Pfizer INC. | $331.55 | 2019-2024 | |
| Abbvie INC. | $239.82 | 2019-2024 | Liletta |
| Exeltis, USA INC. | $180.54 | 2019-2025 | Slynd |
| Ethicon US, LLC | $175.49 | 2023-2025 | Enseal X1, Echelon Circular, Surgicel Nu-Knit |
| Astellas Pharma US INC | $149.95 | 2021-2024 | Veozah |
| Organon LLC | $144.04 | 2021-2025 | Nexplanon |
| Coopersurgical, INC. | $132.11 | 2019-2024 | Paragard T 380a, Endosee |
| Exact Sciences Corporation | $130.81 | 2023-2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $130.61 | 2019-2023 | |
| Therapeuticsmd, INC. | $124.48 | 2020-2022 | |
| Mayne Pharma Commercial LLC | $113.61 | 2021-2025 | |
| Agile Therapeutics, INC. | $97.81 | 2021-2024 | Twirla |
| Evofem Biosciences, INC. | $90.88 | 2021-2024 |
Show all 40 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Myron Strickland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.